About Saranas
Saranas is a Healthcare company based in Houston (United States) founded in 2011. A device is developed for detecting internal bleeding during catheterization. Saranas has raised $29.46 million across 9 funding rounds from investors including Baird Capital, S3 Ventures and Houston Technology Center. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Cardival Medical, Aziyo Biologics and Cordis; 2 of its 3 listed competitors have raised funding.
Company details
Saranas was founded in 2011 and is headquartered in Houston, United States. Operations focus on the medical device sector, where a tool called Early Bird is created to identify internal bleeding risks in catheterization procedures. The device incorporates a cardiac sheath integrated with electrodes that assess electrical resistance variations across blood vessels, supporting safer vascular interventions.
- Headquarters Houston, United States
- SectorsHealthcare
- Website saranas.com
- Social LinkedIn
- Total Equity Funding$29.46M (USD)
in 9 rounds
- Latest Funding Round$15.48M (USD), Series B
Jul 2021
- InvestorsBaird Capital
& 2 more
Funding Insights of Saranas
Saranas has successfully raised a total of $29.46M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $15.48 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $29.46M
- Total Rounds 9
- Last Round Series B — $15.48M
- First Round $50,000
(Apr 2012)
- Investors Count 3
All 9 funding rounds of Saranas with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2021 | $15.48M | Series B | – | Baird Capital | |
| May 2020 | $1.65M | Debt – Conventional | – | – | – |
| May 2018 | $2.8M | Series B | – | – | – |
| May 2017 | $4M | Series B | – | – | – |
| Jul 2016 | $1.43M | Series A | – | – | – |
| Jun 2015 | $4.5M | Series A | – | – | – |
| Aug 2014 | $1.2M | Seed | – | – | – |
| Oct 2013 | $30,000 | Grant | – | – | |
| Apr 2012 | $50,000 | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in Saranas
Saranas has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Baird Capital, S3 Ventures and Houston Technology Center.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global private equity and venture capital investments in B2B Tech & Services companies. | bairdcapital.com | |||
Venture capital investments are provided to Texas-based startups. | 2005 | s3vc.com | Austin, United States | |
| houstontech.org |
Investor details for Saranas
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Saranas
2 people are tracked at Saranas (2 in team).
| Name | Role | Group |
|---|---|---|
Susan Sullivan | Regional Business Manager | Team |
Suzy Oujesky | Regional Business Manager | Team |
Complete people profiles for Saranas
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Saranas
3 dated milestones of Saranas across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Saranas is founded.
- Funding First funding round of $50K.
- Funding Latest funding round, Series B, of $15.5M.
Competitors of Saranas
Saranas has 3 listed competitors in our database, 2 of them funded. They include Cardival Medical, Aziyo Biologics and Cordis.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cardivamedical.com | 2002 | Santa Clara, United States | $169.45M | 158 | A device for vascular access management is developed. | |
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. | |
| cordis.com | 1957 | Fremont, United States | 5 | Cardiovascular and endovascular devices are developed and marketed by Cordis. |
Detailed competitors of Saranas
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Saranas
Websites that share an audience with Saranas (saranas.com).
Websites whose visitors overlap most with Saranas. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| facebook.com | 100% | 12.1B | #3 | View details |
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Saranas (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Saranas
Complete news archive for Saranas
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saranas
Saranas was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Saranas is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Saranas is a funded company, having raised a total of $29.46M across 9 funding rounds to date. The company's 1st funding round was a Seed of $50K, raised on Apr 2012.
Saranas was founded in 2011 and is headquartered in Houston, United States. Operations focus on the medical device sector, where a tool called Early Bird is created to identify internal bleeding risks in catheterization procedures. The device incorporates a cardiac sheath integrated with electrodes that assess electrical resistance variations across blood vessels, supporting safer vascular interventions.
Saranas's top competitors include Cardival Medical, Aziyo Biologics and Cordis.
Saranas has 3 investors. Key investors include Baird Capital, S3 Ventures, and Houston Technology Center.